BRIEF-Hubei Biocause Pharma sees Q1 net profit down after sharp rise in 2016

April 12 (Reuters) - Hubei Biocause Pharmaceutical Co Ltd

* Says preliminary 2016 net profit up 626.0 percent y/y to

1.8 billion yuan ($261.13 million)

* Says it sees Q1 net profit to fall 84.9-87.4 percent y/y

to 100-120 million yuan

* Says insurance unit's Q1 premium income at 22.3 billion

yuan

Source text in Chinese: http://bit.ly/2p4ojSb;

http://bit.ly/2p4APRy; http://bit.ly/2orQ05Z

Further company coverage:

($1 = 6.8931 Chinese yuan renminbi)

(Reporting by Hong Kong newsroom)